Bank Of Nova Scotia Pfizer Inc Put Options Transaction History

Bank Of Nova Scotia

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2025 Nov 14, 2025	BUY	$23.29 - $25.88 $58,225 - $64,700	2,500 Added 63.29%	6,450 $164,000
Q2 2025 Aug 13, 2025	SELL	$21.59 - $24.84 $58,422 - $67,217	-2,706 Reduced 40.66%	3,950 $95,000
Q1 2025 Jul 02, 2025	SELL	$25.01 - $27.13 $10,004 - $10,852	-400 Reduced 5.67%	6,656 $168,000
Q1 2025 May 09, 2025	SELL	$25.01 - $27.13 $10,004 - $10,852	-400 Reduced 5.67%	6,656 $168,000
Q4 2024 Jul 02, 2025	BUY	$24.8 - $30.19 $9,920 - $12,076	400 Added 6.01%	7,056 $187,000
Q4 2024 Feb 13, 2025	BUY	$24.8 - $30.19 $21,080 - $25,661	850 Added 13.7%	7,056 $187,000
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $45,619 - $53,457	1,806 Added 41.05%	6,206 $173,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $113,916 - $130,812	4,400 New	4,400 $122,000

3,350

3.57B

87.2M

106M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.